Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Teva
Express Scripts
QuintilesIMS
Citi
UBS
Baxter
US Department of Justice
Colorcon

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050324

« Back to Dashboard

NDA 050324 describes NEODECADRON, which is a drug marketed by Merck and is included in two NDAs. Additional details are available on the NEODECADRON profile page.

The generic ingredient in NEODECADRON is dexamethasone sodium phosphate; neomycin sulfate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; neomycin sulfate profile page.
Summary for 050324
Tradename:NEODECADRON
Applicant:Merck
Ingredient:dexamethasone sodium phosphate; neomycin sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;OPHTHALMICStrengthEQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
UBS
Moodys
Queensland Health
AstraZeneca
Johnson and Johnson
Cipla
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.